开展慢性难愈合创面防控的创新理论与关键措施研究以满足国家重大需求的理论与实践

来源 :第十届全国创伤修复(愈合)与组织再生学术会议、第三届中欧创面修复学术会议、中国医师协会创伤外科医师分会创面修复医师专业委 | 被引量 : 0次 | 上传用户:scfeiyang
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
其他文献
  Background: Both clinical outcomes and safety of second-line therapy of Icotinib or Gefitinib for advanced non-small cell lung cancer(NSCLC)patients harbori
会议
  本文研究政府卫生支出对居民健康水平的影响,以新生儿死亡率作为衡量居民健康水平指标,运用中国卫生统计年鉴2013 年的数据,来衡量我国居民的健康水平。运用Grossman 模型和
  “十二五”计划将生物医药产业定为我国七大战略新兴产业之一,产业发展逐渐受到政府和企业关注。生物医药上市公司作为生物医药行业代表,其经营情况在一定程度上反映了产业
会议
  Classic pharmacokinetics based on the detection of drug plasma concentration often seems difficult to evaluate the efficacy because of the mismatch of pharm
会议
  Multi-drug resistance(MDR)is a major obstacle to successful chemotherapy of cancer.To overcome the MDR,our research is to develop new liposome and nanomicel
会议
会议
  The cancer drug delivery process is a cascade of five steps consisting of Circulation in blood,Accumulation and Penetration into the tumor,cellular Internal
会议
  Druggability of natural active compounds has been the most critical scientific question in the research and development of natural product-based novel drugs
会议
  Multidrug resistance(MDR)is the primary cause of cancer chemotherapy failure.The main mechanisms of MDR are that MDR cancer cells have reduced uptake and in